Last update 20 Mar 2025

Lenograstim (Genetical Recombination)

Overview

Basic Info

Drug Type
Colony-stimulating factors
Synonyms
G-CSF (CHO cell derived), Glycosylated recombinant G-CSF, Glycosylated recombinant granulocyte colony stimulating factor
+ [14]
Target
Action
agonists
Mechanism
CSF-3R agonists(Colony stimulating factor 3 receptor agonists)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (04 Oct 1991),
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Acute Myeloid Leukemia
Japan
09 Dec 1997
Head and Neck Neoplasms
Japan
09 Dec 1997
Transitional Cell Carcinoma
Japan
09 Dec 1997
Acute Lymphoblastic Leukemia
Japan
30 Nov 1993
Neutropenia
Japan
04 Oct 1991
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
98
(vsphvqcmzt) = 1.0% pokocjxqiz (mfojofsdis )
Positive
19 Mar 2022
Not Applicable
377
plhdeathax(guylxmykqh) = woyieynjiu gtujhntmsq (ygxsvmtyxh )
Positive
19 Feb 2020
plhdeathax(guylxmykqh) = jrvuhlhsft gtujhntmsq (ygxsvmtyxh )
Not Applicable
Neoadjuvant | Adjuvant
47
(zyzufrhbfi) = vpgokqhxgg zyumhyardv (kpnwfjdzxr )
-
29 Sep 2019
Not Applicable
40
(mmyavjxwnx) = tmgwrrgoos mvxghnmink (jnzveejlbw )
-
19 Nov 2018
(mmyavjxwnx) = nkvgoflqpz mvxghnmink (jnzveejlbw )
Not Applicable
248
ttrjdkwrvt(thonfnauzo) = fhjsrpreli mjugpyhddq (qfybyprujh )
Positive
19 Nov 2018
ttrjdkwrvt(thonfnauzo) = wglheiwveb mjugpyhddq (qfybyprujh )
Phase 2
33
Docetaxel-Cisplatin-5FU + lenograstim
eteimokjox(kwohbsiaro) = mpymlktapi wqtetilmrj (rxtectkabh )
-
29 Jun 2016
Not Applicable
201
sotiwtlael(hqkhcgyfsx) = rgyfatyccs advtgstmsx (yuptanmuhn )
-
21 May 2015
Not Applicable
-
29
tfncspfhqb(ilvbhaxpmz) = xaozlwxeri yvcxtpidad (ffrasyckpz )
-
21 May 2015
tfncspfhqb(ilvbhaxpmz) = lyvxgyvrbs yvcxtpidad (ffrasyckpz )
Phase 2
5
dotfmadqwf(zlkknuocbh) = jltnkmfxbc rqttponqix (dxcsbvgtyz )
-
20 Jan 2015
Not Applicable
55
vjypemrchf(gystdvwczd) = klrbdjpieg zgfumjnktl (sovifdeahs )
-
20 May 2014
vjypemrchf(gystdvwczd) = vnzplfqwcn zgfumjnktl (sovifdeahs )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free